Connor, Clark & Lunn Investment Management Ltd.

Position in FLGT — Fulgent Genetics, Inc.

CIK 1596800 VANCOUVER, A1

Back to FLGT Full portfolio

Position in FLGT

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$3,264,896

-$1,545,871 QoQ

Shares Held

159,108

-47.4% QoQ

Ownership

0.578%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#27

of 142 holders

Holding Since

Dec 2021

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in FLGT Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $189,818,037 across 16 Diagnostics & Research names. FLGT ranks #11 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MEDP	Medpace Holdings, Inc.	110,353	$58,441,845
2	GH	Guardant Health, Inc.	215,395	$32,315,711
3	DHR	Danaher Corp /De/	114,010	$21,716,624
4	TMO	Thermo Fisher Scientific Inc.	36,269	$18,183,825
5	NEO	Neogenomics Inc	802,597	$11,709,889
6	RVTY	Revvity, Inc.	87,145	$9,695,752
7	MYGN	Myriad Genetics Inc	1,407,860	$8,038,880
8	CSTL	Castle Biosciences Inc	331,727	$7,911,688

All Filings in FLGT

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,264,896	159,108	-47.4%	Shares	Sole	2026-08-13
2026-03-31	$4,810,767	302,564	-19.3%	Shares	Sole	2026-05-11
2025-12-31	$9,846,652	374,825	+13.1%	Shares	Sole	2026-02-10
2025-09-30	$7,492,487	331,526	+8.6%	Shares	Sole	2025-11-13
2025-06-30	$6,066,978	305,180	+22.2%	Shares	Sole	2025-08-07
2025-03-31	$4,219,237	249,659	+98.2%	Shares	Sole	2025-05-12
2024-12-31	$2,326,425	125,957	+803.2%	Shares	Sole	2025-02-10
2024-09-30	$303,046	13,946	+109.7%	Shares	Sole	2024-11-08
2021-12-31	$668,822	6,649	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.